-
公开(公告)号:US07572797B2
公开(公告)日:2009-08-11
申请号:US11556354
申请日:2006-11-03
申请人: Stephen Mark Denton , Karl Richard Gibson , Melanie Susanne Glossop , Mark Ian Kemp , Cedric Poinsard
发明人: Stephen Mark Denton , Karl Richard Gibson , Melanie Susanne Glossop , Mark Ian Kemp , Cedric Poinsard
IPC分类号: A61K31/497
CPC分类号: C07D403/12 , C07D413/12
摘要: The present invention relates to compounds of the formula and pharmaceutically acceptable salts and solvates thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds for the treatment of pain.
摘要翻译: 本发明涉及下式的化合物及其药学上可接受的盐和溶剂化物,其制备方法,用于制备的中间体和含有这些化合物的组合物以及这些化合物用于治疗疼痛的用途。
-
公开(公告)号:US08134007B2
公开(公告)日:2012-03-13
申请号:US12114258
申请日:2008-05-02
申请人: Sharanjeet Kaur Bagal , Karl Richard Gibson , Mark Ian Kemp , Cedric Poinsard , Blanda Luzia Stammen , Stephen Martin Denton , Melanie Susanne Glossop
发明人: Sharanjeet Kaur Bagal , Karl Richard Gibson , Mark Ian Kemp , Cedric Poinsard , Blanda Luzia Stammen , Stephen Martin Denton , Melanie Susanne Glossop
IPC分类号: C07D413/12 , C07D413/14 , C07D401/12 , C07D401/14 , A61K31/4418 , A61K31/4427 , A61K31/443 , A61K31/4439
CPC分类号: C07D401/12 , C07D213/75 , C07D413/12
摘要: The present invention relates to compounds of the formula (I): and pharmaceutically acceptable salts thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds for the treatment of pain.
摘要翻译: 本发明涉及式(I)化合物及其药学上可接受的盐,用于制备用于制备中间体的方法和含有这些化合物的组合物以及这些化合物用于治疗疼痛的用途。
-
公开(公告)号:US20090048306A1
公开(公告)日:2009-02-19
申请号:US12114258
申请日:2008-05-02
申请人: Sharanjeet Kaur Bagal , Karl Richard Gibson , Mark Ian Kemp , Cedric Poinsard , Blanda Luzia Christa Stammen , Stephen Martin Denton , Melanie Susanne Glossop
发明人: Sharanjeet Kaur Bagal , Karl Richard Gibson , Mark Ian Kemp , Cedric Poinsard , Blanda Luzia Christa Stammen , Stephen Martin Denton , Melanie Susanne Glossop
IPC分类号: A61K31/4439 , C07D401/12 , A61P25/04
CPC分类号: C07D401/12 , C07D213/75 , C07D413/12
摘要: The present invention relates to compounds of the formula (I): and pharmaceutically acceptable salts thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds for the treatment of pain.
摘要翻译: 本发明涉及式(I)化合物及其药学上可接受的盐,用于制备用于制备中间体的方法和含有这些化合物的组合物以及这些化合物用于治疗疼痛的用途。
-
公开(公告)号:US20100240652A1
公开(公告)日:2010-09-23
申请号:US12161239
申请日:2007-01-15
IPC分类号: A61K31/4418 , C07D213/83 , C07D213/78 , C07D413/06 , A61K31/5377 , A61P29/00
CPC分类号: C07D213/81 , C07D213/83 , C07D213/84
摘要: The present invention relates to compounds of the formula (I) and pharmaceutically acceptable salts and solvates thereof, to processes for the preparation of, intermediates used in the preparation of, and compositions containing such compounds and the uses of such compounds for the treatment of pain.
摘要翻译: 本发明涉及式(I)化合物及其药学上可接受的盐和溶剂合物,其制备方法,用于制备的中间体和含有这些化合物的组合物以及这些化合物用于治疗疼痛的用途 。
-
公开(公告)号:US20080096950A1
公开(公告)日:2008-04-24
申请号:US11866565
申请日:2007-10-03
IPC分类号: A61K31/4155 , A61P43/00 , C07D231/18
CPC分类号: C07D405/04 , C07D409/04
摘要: Compounds of Formula (I): and pharmaceutically acceptable salts, solvates (including hydrates) of said compounds and salts, or prodrugs of said compound, or pharmaceutically acceptable salts or solvates of said prodrugs, wherein the substituents are as herein defined, are useful in therapy, for example they may be useful for treating progesterone-mediated conditions such as endometriosis, uterine fibroids (leiomyomata), menorrhagia, adenomyosis, primary and secondary dysmenorrhoea (including symptoms of dyspareunia, dyschexia and chronic pelvic pain), or chronic pelvic pain syndrome.
摘要翻译: 式(I)化合物及其药学上可接受的盐,所述化合物和盐的溶剂合物(包括水合物)或所述化合物的前药或所述前体药物的药学上可接受的盐或溶剂合物,其中取代基如本文所定义,可用于 治疗,例如它们可用于治疗孕激素介导的病症如子宫内膜异位症,子宫肌瘤(平滑肌瘤),月经过多,子宫腺肌症,原发性和继发性痛经(包括性交疼痛症状,经济症状和慢性盆腔疼痛)或慢性盆腔疼痛综合征 。
-
公开(公告)号:US06337331B1
公开(公告)日:2002-01-08
申请号:US09700003
申请日:2000-11-08
申请人: Howard Barff Broughton , Jose Luis Castro Pineiro , Ian James Collins , Karl Richard Gibson , Michael Rowley , Leslie Joseph Street
发明人: Howard Barff Broughton , Jose Luis Castro Pineiro , Ian James Collins , Karl Richard Gibson , Michael Rowley , Leslie Joseph Street
IPC分类号: A61K31505
CPC分类号: C07D487/04
摘要: Substituted or 6,7-ring fused 1,2,3-triazolo[1,5-&agr;]-pyrimidine derivatives are selective ligands for GABAA receptors useful in the treatment of disorders of the central nervous system, including anxiety and convulsions.
摘要翻译: 取代或6,7环稠合的1,2,3-三唑并[1,5-a]嘧啶衍生物是用于治疗中枢神经系统疾病(包括焦虑和抽搐)的GABA A受体的选择性配体。
-
公开(公告)号:US08809363B2
公开(公告)日:2014-08-19
申请号:US13295167
申请日:2011-11-14
申请人: Andrew Simon Bell , Iain Brian Gardner , Karl Richard Gibson , David Cameron Pryde , Florian Michel Wakenhut
发明人: Andrew Simon Bell , Iain Brian Gardner , Karl Richard Gibson , David Cameron Pryde , Florian Michel Wakenhut
IPC分类号: A61K31/44
CPC分类号: C07D495/04 , A61K31/4365 , A61K31/437 , A61K31/444 , A61K31/506 , A61K45/06 , C07D495/14 , C07D519/00
摘要: The present invention relates to novel 2,3,4-substituted 5,6,7,8-tetrahydro[1]benzothieno[2,3-b]pyridine compounds and pharmaceutically acceptable salts thereof, to compositions containing such compounds and to the use of such compounds as inhibitors of HIV replication.
摘要翻译: 本发明涉及新的2,3,4-取代5,6,7,8-四氢[1]苯并噻吩并[2,3-b]吡啶化合物及其药学上可接受的盐,涉及含有这些化合物的组合物及其用途 的这种化合物作为HIV复制的抑制剂。
-
公开(公告)号:US20120136023A1
公开(公告)日:2012-05-31
申请号:US13295167
申请日:2011-11-14
申请人: Andrew Simon Bell , Iain Brian Gardner , Karl Richard Gibson , David Cameron Pryde , Florian Michel Wakenhut
发明人: Andrew Simon Bell , Iain Brian Gardner , Karl Richard Gibson , David Cameron Pryde , Florian Michel Wakenhut
IPC分类号: A61K31/4365 , C07D495/14 , A61P31/18 , C07D495/04
CPC分类号: C07D495/04 , A61K31/4365 , A61K31/437 , A61K31/444 , A61K31/506 , A61K45/06 , C07D495/14 , C07D519/00
摘要: The present invention relates to novel 2,3,4-substituted 5,6,7,8-tetrahydro[1]benzothieno[2,3-b]pyridine compounds and pharmaceutically acceptable salts thereof, to compositions containing such compounds and to the use of such compounds as inhibitors of HIV replication.
摘要翻译: 本发明涉及新的2,3,4-取代5,6,7,8-四氢[1]苯并噻吩并[2,3-b]吡啶化合物及其药学上可接受的盐,涉及含有这些化合物的组合物及其用途 的这种化合物作为HIV复制的抑制剂。
-
公开(公告)号:US08232269B2
公开(公告)日:2012-07-31
申请号:US12561398
申请日:2009-09-17
IPC分类号: A61K31/397 , A61K31/415 , A61K31/506 , A61K31/4184 , A61K31/454 , C07D231/20 , C07D205/04 , C07D403/12 , C07D235/02 , C07D401/12
CPC分类号: C07D231/14 , C07D231/16 , C07D403/12 , C07D405/04 , C07D405/12 , C07D409/12 , C07D487/04
摘要: A compound of Formula (I), or a pharmaceutically acceptable salt or solvate thereof, wherein, R1 and R2 each independently represent H, halogen, CF3, C1-3 alkyl or C1-3 alkoxy; R3 represents C1-6 alkyl, C3-6 cycloalkyl, phenyl (optionally substituted by one or more substituents each independently selected from Ra) or Het (optionally substituted by one or more substituents each independently selected from OH, oxo, or C1-4 alkyl); R4 represents H or C1-3 alkyl; R5 represents C1-6 alkyl (optionally substituted by one or more substituents each independently selected from Rb), C3-6 cycloalkyl (optionally substituted by one or more substituents each independently selected from oxo or OH), or Het2 (optionally substituted by one or more substituents each independently selected from Rd); oxygen atom or 1 sulphur atom, or (c) 1 oxygen atom or 1 sulphur atom, (optionally substituted by one or more substituents each independently selected from OH, oxo or C1-4 alkyl); and R6 represents C1-3 alkyl (optionally substituted by one or more substituents each independently selected from Rf), C3-5 cycloalkyl (optionally substituted by one or more halogen), CN or halogen; where Rf represents halogen or phenyl: and compositions, processes for the preparation, and uses thereof, e.g. in the treatment of endometriosis or uterine fibroids.
摘要翻译: 式(I)的化合物或其药学上可接受的盐或溶剂合物,其中R 1和R 2各自独立地表示H,卤素,CF 3,C 1-3烷基或C 1-3烷氧基; R 3表示C 1-6烷基,C 3-6环烷基,苯基(任选被一个或多个各自独立地选自Ra的取代基)或Het(任选被一个或多个各自独立地选自OH,氧代或C 1-4烷基的取代基取代) ); R 4表示H或C 1-3烷基; R 5表示C 1-6烷基(任选被一个或多个独立地选自Rb的取代基取代),C 3-6环烷基(任选地被一个或多个独立地选自氧代或OH的取代基取代)或Het2(任选被一个或多个 更多取代基,各自独立地选自Rd); 氧原子或1个硫原子,或(c)1个氧原子或1个硫原子(任选被一个或多个独立地选自OH,氧代或C 1-4烷基的取代基取代); 和R 6表示C 1-3烷基(任选被一个或多个独立地选自Rf的取代基取代),C3-5环烷基(任选被一个或多个卤素取代),CN或卤素; 其中R f表示卤素或苯基;和组合物,制备方法及其用途,例如, 治疗子宫内膜异位症或子宫肌瘤。
-
公开(公告)号:US20100249091A1
公开(公告)日:2010-09-30
申请号:US12561398
申请日:2009-09-17
IPC分类号: A61K31/397 , C07D231/20 , A61K31/415 , C07D205/04 , C07D403/12 , A61K31/506 , C07D235/02 , A61K31/4184 , C07D401/12 , A61K31/454 , A61P35/00 , A61P29/00
CPC分类号: C07D231/14 , C07D231/16 , C07D403/12 , C07D405/04 , C07D405/12 , C07D409/12 , C07D487/04
摘要: A compound of Formula (I), or a pharmaceutically acceptable salt or solvate thereof, wherein, R1 and R2 each independently represent H, halogen, CF3, C1-3 alkyl or C1-3 alkoxy; R3 represents C1-6 alkyl, C3-6 cycloalkyl, phenyl (optionally substituted by one or more substituents each independently selected from Ra) or Het (optionally substituted by one or more substituents each independently selected from OH, oxo, or C1-4 alkyl); R4 represents H or C1-3 alkyl; R5 represents C1-6 alkyl (optionally substituted by one or more substituents each independently selected from Rb), C3-6 cycloalkyl (optionally substituted by one or more substituents each independently selected from oxo or OH), or Het2 (optionally substituted by one or more substituents each independently selected from Rd); oxygen atom or 1 sulphur atom, or (c) 1 oxygen atom or 1 sulphur atom, (optionally substituted by one or more substituents each independently selected from OH, oxo or C1-4 alkyl); and R6 represents C1-3 alkyl (optionally substituted by one or more substituents each independently selected from Rf), C3-5 cycloalkyl (optionally substituted by one or more halogen), CN or halogen; where Rf represents halogen or phenyl: and compositions, processes for the preparation, and uses thereof, e.g. in the treatment of endometriosis or uterine fibroids
摘要翻译: 式(I)的化合物或其药学上可接受的盐或溶剂合物,其中R 1和R 2各自独立地表示H,卤素,CF 3,C 1-3烷基或C 1-3烷氧基; R 3表示C 1-6烷基,C 3-6环烷基,苯基(任选被一个或多个各自独立地选自Ra的取代基)或Het(任选被一个或多个各自独立地选自OH,氧代或C 1-4烷基的取代基取代) ); R 4表示H或C 1-3烷基; R 5表示C 1-6烷基(任选被一个或多个独立地选自Rb的取代基取代),C 3-6环烷基(任选地被一个或多个独立地选自氧代或OH的取代基取代)或Het2(任选被一个或多个 更多取代基,各自独立地选自Rd); 氧原子或1个硫原子,或(c)1个氧原子或1个硫原子(任选被一个或多个独立地选自OH,氧代或C 1-4烷基的取代基取代); 和R 6表示C 1-3烷基(任选被一个或多个独立地选自Rf的取代基取代),C3-5环烷基(任选被一个或多个卤素取代),CN或卤素; 其中R f表示卤素或苯基;和组合物,制备方法及其用途,例如, 治疗子宫内膜异位症或子宫肌瘤
-
-
-
-
-
-
-
-
-